Lb Pharmaceuticals LBRX
NASDAQ LBRX
$37.04 -0.24 (-0.64%)
As of: Oct 2, 2026 · 12:31 PM EDT

Lb Pharmaceuticals (LBRX) Accumulated Expenses (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) reported Accumulated Expenses of $19.23 million for Q2 2026, up 529.0% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals posted Accumulated Expenses of $4.59 million, down 13.5% from FY2024.

  • By year, Accumulated Expenses came in at $5.3 million in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.06 million (Q1 2026), $4.59 million (Q4 2025) and $3.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.23 Mn
Mar 31, 2026 3.06 Mn
Dec 31, 2025 4.59 Mn
Sep 30, 2025 3.33 Mn
Dec 31, 2024 5.30 Mn
API Access

Lb Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LBRX&period=max&api_key=YOUR_API_KEY